XI398

XI398 is a chemical compound with the molecular formula C10H14N2O2. It is a derivative of the benzodiazepine class of drugs, specifically a triazolobenzodiazepine. The compound was first synthesized in the late 20th century and has since been studied for its potential therapeutic applications.

XI398 exhibits anxiolytic, sedative-hypnotic, and muscle relaxant properties, similar to other benzodiazepines. It is believed to act on the central nervous system by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits nerve cell activity. This action leads to a calming effect on the brain and body.

The compound has been investigated for its potential use in the treatment of anxiety disorders, insomnia, and muscle spasms. However, like other benzodiazepines, XI398 carries a risk of dependence and should be used with caution. Its safety profile and efficacy have not been extensively studied, and more research is needed to fully understand its potential benefits and risks.

XI398 is not currently available on the market and is primarily of interest to researchers and scientists studying the pharmacology of benzodiazepines. Its synthesis and characterization have been documented in scientific literature, providing a foundation for further investigation into its potential therapeutic applications.